纳米孔测序区分水痘-带状疱疹病毒野毒株与疫苗株
该研究回顾性分析水痘-带状疱疹病毒(VZV)感染患者的疱疹液和脑脊液样本,以等位基因鉴别实时PCR和直接测序已鉴定的野毒株与疫苗株各1例为对照,对10例VZV株未明样本进行针对ORF62区的长PCR及纳米孔测序。纳米孔测序确认了先前报道的位点(105705、106262、107136和107252)的单核苷酸多态性(SNPs),10例未明样本中9例为野毒株、1例为疫苗株,且在VZV DNA水平低的样本中仍有效。研究验证纳米孔测序是区分VZV野毒株与疫苗株的可靠方法。
要点
- 纳米孔测序可确认VZV ORF62区已知SNP位点并区分野毒株与疫苗株。
- 10例VZV株未明样本中,9例鉴定为野毒株、1例为疫苗株。
- 在VZV DNA水平低的样本中纳米孔测序仍能有效鉴定株型。
核心结论
- 本研究验证纳米孔测序是区分VZV野毒株与疫苗株的可靠方法,能同时确认已知SNP并检测新突变,可作为快速精准鉴定野毒株与疫苗株的有价值工具,并有望用于未来VZV监测。
研究设计与样本
- 回顾性研究,检测VZV感染患者的疱疹液和脑脊液样本;以等位基因鉴别实时PCR和直接测序已鉴定的野毒株与疫苗株各1例为对照,纳入10例VZV株未明样本。
- DNA提取后针对VZV ORF62区进行长PCR,再以纳米孔测序鉴定SNP以区分疫苗株与野毒株。
主要发现
- 纳米孔测序确认了先前报道的位点(105705、106262、107136和107252)的SNP,有助于区分野毒株与疫苗株。
- 10例未明样本中,9例鉴定为野毒株、1例为疫苗株。
- 在VZV DNA水平低的样本中,纳米孔测序仍能有效鉴定株型。
关键数值与推荐
- 纳米孔测序确认的SNP位点为105705、106262、107136和107252。
- 10例VZV株未明样本中,9例为野毒株、1例为疫苗株。
临床怎么用
- 原文结论认为纳米孔测序可作为快速精准鉴定VZV野毒株与疫苗株的有价值工具,并有望用于未来VZV监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The introduction of varicella vaccines into routine pediatric immunization programs has led to a considerable reduction in varicella incidence. However, there have been reports of varicella, herpes zoster, and meningitis caused by the vaccine strain of varicella-zoster virus (VZV), raising concerns. Establishing the relationship between the wild-type and vaccine strains in VZV infections among previously vaccinated individuals is crucial. Differences in the single nucleotide polymorphisms (SNPs) among vaccine strains can be utilized to identify the strain. In this study, we employed nanopore sequencing to identify VZV strains and analyzed clinical samples. METHODS: We retrospectively examined vesicle and cerebrospinal fluid samples from patients with VZV infections. One sample each of the wild-type and vaccine strains, previously identified using allelic discrimination real-time PCR and direct sequencing, served as controls. Ten samples with undetermined VZV strains were included. After DNA extraction, a long PCR targeting the VZV ORF62 region was executed. Nanopore sequencing identified SNPs, allowing discrimination between the vaccine and wild-type strains. RESULTS: Nanopore sequencing confirmed SNPs at previously reported sites (105,705, 106,262, 107,136, and 107,252), aiding in distinguishing between wild-type and vaccine strains. Among the ten unknown samples, nine were characterized as wild strains and one as a vaccine strain. Even in samples with low VZV DNA levels, nanopore sequencing was effective in strain identification. CONCLUSION: This study validates that nanopore sequencing is a reliable method for differentiating between the wild-type and vaccine strains of VZV. Its ability to produce long-read sequences is remarkable, allowing simultaneous confirmation of known SNPs and the detection of new mutations. Nanopore sequencing can serve as a valuable tool for the swift and precise identification of wild-type and vaccine strains and has potential applications in future VZV surveillance.
引用
- Fukuda Y, Suzuki T, Iwata KI, et al. Nanopore sequencing in distinguishing between wild-type and vaccine strains of Varicella-Zoster virus. Vaccine. 2024. PMID: 38548526. doi:10.1016/j.vaccine.2024.03.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。